112 related articles for article (PubMed ID: 12742821)
1. Expression levels strongly affect ligand-induced sequestration of B2 bradykinin receptors in transfected cells.
Faussner A; Bauer A; Kalatskaya I; Jochum M; Fritz H
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H1892-8. PubMed ID: 12742821
[TBL] [Abstract][Full Text] [Related]
2. Influence of the cytosolic carboxyl termini of human B1 and B2 kinin receptors on receptor sequestration, ligand internalization, and signal transduction.
Faussner A; Proud D; Towns M; Bathon JM
J Biol Chem; 1998 Jan; 273(5):2617-23. PubMed ID: 9446564
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin-induced internalization of the human B2 receptor requires phosphorylation of three serine and two threonine residues at its carboxyl tail.
Pizard A; Blaukat A; Müller-Esterl W; Alhenc-Gelas F; Rajerison RM
J Biol Chem; 1999 Apr; 274(18):12738-47. PubMed ID: 10212257
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the responses of B1 and B2 kinin receptors to agonist stimulation.
Faussner A; Bathon JM; Proud D
Immunopharmacology; 1999 Dec; 45(1-3):13-20. PubMed ID: 10614984
[TBL] [Abstract][Full Text] [Related]
5. Negative cooperativity in the human bradykinin B2 receptor.
Pizard A; Marchetti J; Allegrini J; Alhenc-Gelas F; Rajerison RM
J Biol Chem; 1998 Jan; 273(3):1309-15. PubMed ID: 9430662
[TBL] [Abstract][Full Text] [Related]
6. B2 kinin receptor-mediated internalization of bradykinin in DDT1 MF-2 smooth muscle cells is paralleled by sequestration of the occupied receptors.
Munoz CM; Cotecchia S; Leeb-Lundberg LM
Arch Biochem Biophys; 1993 Mar; 301(2):336-44. PubMed ID: 8384832
[TBL] [Abstract][Full Text] [Related]
7. Agonist-induced translocation of the kinin B(1) receptor to caveolae-related rafts.
Sabourin T; Bastien L; Bachvarov DR; Marceau F
Mol Pharmacol; 2002 Mar; 61(3):546-53. PubMed ID: 11854434
[TBL] [Abstract][Full Text] [Related]
8. Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways.
Austin CE; Faussner A; Robinson HE; Chakravarty S; Kyle DJ; Bathon JM; Proud D
J Biol Chem; 1997 Apr; 272(17):11420-5. PubMed ID: 9111052
[TBL] [Abstract][Full Text] [Related]
9. Functional studies of bradykinin receptors in Chinese hamster ovary cells stably expressing the human B2 bradykinin receptor.
Zhang SP; Wang HY; Lovenberg TW; Codd EE
Int Immunopharmacol; 2001 May; 1(5):955-65. PubMed ID: 11379050
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ release and Ca2+ influx in Chinese hamster ovary cells expressing the cloned mouse B2 bradykinin receptor: tyrosine kinase inhibitor-sensitive and- insensitive processes.
Taketo M; Yokoyama S; Kimura Y; Higashida H
Biochim Biophys Acta; 1997 Jan; 1355(1):89-98. PubMed ID: 9030205
[TBL] [Abstract][Full Text] [Related]
12. Changes in amino-terminal portion of human B2 receptor selectively increase efficacy of synthetic ligand HOE 140 but not of cognate ligand bradykinin.
Schroeder C; Breit A; Böning H; Dedio J; Gera L; Stewart J; Müller-Esterl W
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H1924-32. PubMed ID: 12574004
[TBL] [Abstract][Full Text] [Related]
13. Palmitoylation of the human bradykinin B2 receptor influences ligand efficacy.
Pizard A; Blaukat A; Michineau S; Dikic I; Müller-Esterl W; Alhenc-Gelas F; Rajerison RM
Biochemistry; 2001 Dec; 40(51):15743-51. PubMed ID: 11747451
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates.
Bachvarov DR; Houle S; Bachvarova M; Bouthillier J; Adam A; Marceau F
J Pharmacol Exp Ther; 2001 Apr; 297(1):19-26. PubMed ID: 11259523
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.
Robert C; Pruneau D; Paquet JL
Br J Pharmacol; 2002 Jan; 135(2):462-8. PubMed ID: 11815382
[TBL] [Abstract][Full Text] [Related]
16. Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane.
Hecquet C; Becker RP; Tan F; Erdös EG
Int Immunopharmacol; 2002 Dec; 2(13-14):1795-806. PubMed ID: 12489794
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of bradykinin and resensitization of its B2 receptor.
Marcic B; Deddish PA; Jackman HL; Erdös EG
Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
[TBL] [Abstract][Full Text] [Related]
18. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.
Hecquet C; Tan F; Marcic BM; Erdös EG
Mol Pharmacol; 2000 Oct; 58(4):828-36. PubMed ID: 10999954
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
[TBL] [Abstract][Full Text] [Related]
20. Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor.
Houle S; Larrivée JF; Bachvarova M; Bouthillier J; Bachvarov DR; Marceau F
Hypertension; 2000 Jun; 35(6):1319-25. PubMed ID: 10856284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
